Recombinant KIR3DL2 (Lacutamab Biosimilar) anticorps

N° du produit ABIN7597768

L’anticorps anti-KIR3DL2 (Lacutamab Biosimilar) Chimeric Humanized est utilisé pour la détection de KIR3DL2 (Lacutamab Biosimilar) dans des échantillons de Humain.

Aperçu rapide pour Recombinant KIR3DL2 (Lacutamab Biosimilar) anticorps (ABIN7597768)

Antigène: KIR3DL2 (Lacutamab Biosimilar)

Type d'anticorp: Recombinant Antibody

Reactivité: Humain

Hôte: Humanized

Clonalité: Chimeric

Conjugué: Cet anticorp KIR3DL2 (Lacutamab Biosimilar) est non-conjugé

Application: Veuillez nous consulter SVP

Classe de qualité: Research Grade

Détail du produit anti-KIR3DL2 (Lacutamab Biosimilar) anticorps

Expression System: Mammalian cells

Fonction: Research Grade Lacutamab Biosimilar Antibody

Specificité: CD158K, MHC class I NK cell receptor, NKAT4, Natural killer-associated transcript 4, KIR3DL2, p70 NK receptor CL-5, CD158k, p70 natural killer cell receptor clone CL-5, CD158 antigen-like family member K, Killer cell immunoglobulin-like receptor 3DL2, NKAT-4

Purification: Protein A or G purified from cell culture supernatant.

Pureté: >95 % by SDS-PAGE.

Isotype: IgG1 kappa

Information d'application

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 mg/mL

Buffer: 0.01M PBS, pH 7.4.

Stock: 4 °C,-20 °C,-80 °C

Stockage commentaire: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Date de péremption: 12 months

Détails sur KIR3DL2 (Lacutamab Biosimilar)

Antigène: KIR3DL2 (Lacutamab Biosimilar)

Autre désignation: Lacutamab Biosimilar

Classe de substances: Biosimilar

Sujet: CD158K, MHC class I NK cell receptor, NKAT4, Natural killer-associated transcript 4, KIR3DL2, p70 NK receptor CL-5, CD158k, p70 natural killer cell receptor clone CL-5, CD158 antigen-like family member K, Killer cell immunoglobulin-like receptor 3DL2, NKAT-4

UniProt: P43630

Numéro CAS: 2187368-16-5